source
- Roche stresses careful AI token use and pauses drug from Carmot acquisitionRoche's CEO Thomas Schinecker said the company is adopting a thoughtful approach to how it employs AI tokens, emphasizing responsible use. He noted that AI tools have already helped increase the n…
- Verdiva Bio appoints former Metsera CMO Steve Marso as it nears key obesity pill readoutsVerdiva Bio, a developer of a long-acting oral obesity treatment, announced the appointment of Steve Marso as its chief medical officer. Marso joins from Metsera, a biotech that pursued similar GL…